Answers are grounded in this paper and cite their sources.
This multicenter real-world study reveals hypoalbuminemia as a prognostic factor in metastatic urothelial carcinoma treated with avelumab therapy, suggesting nutritional support may enhance outcomes.
Hypoalbuminemia was an independent prognostic factor in patients with mUC who were treated with maintenance avelumab therapy. Efforts to preserve nutritional status and avoid hypoalbuminemia may help optimize its efficacy.
No takes yet. Share an insight, caveat, or question.
Muta et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: